 | Up a level |
Stahl, Mirjam; Roehmel, Jobst; Eichinger, Monika; Doellinger, Felix; Naehrlich, Lutz; Kopp, Matthias V; Dittrich, Anna-Maria; Lee, Christopher; Sommerburg, Olaf; Tian, Simon; Xu, Tu; Wu, Pan; Joshi, Aniket; Ray, Partha; Duncan, Margaret E; Wielpütz, Mark O; Mall, Marcus A (2023). Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. Annals of the American Thoracic Society, 20(8), pp. 1144-1155. American Thoracic Society 10.1513/AnnalsATS.202208-684OC
Santangelo, James S; Ness, Rob W; Cohan, Beata; Fitzpatrick, Connor R; Innes, Simon G; Koch, Sophie; Miles, Lindsay S; Munim, Samreen; Peres-Neto, Pedro R; Prashad, Cindy; Tong, Alex T; Aguirre, Windsor E; Akinwole, Philips O; Alberti, Marina; Álvarez, Jackie; Anderson, Jill T; Anderson, Joseph J; Ando, Yoshino; Andrew, Nigel R; Angeoletto, Fabio; ... (2022). Global urban environmental change drives adaptation in white clover. Science, 375(6586), pp. 1275-1281. American Association for the Advancement of Science 10.1126/science.abk0989
Miró, Òscar; Galicia, Miguel; Dargan, Paul; Dines, Alison M; Giraudon, Isabelle; Heyerdahl, Fridtjof; Hovda, Knut E; Yates, Christopher; Wood, David M; Liakoni, Evangelia; Liechti, Matthias; Jürgens, Gesche; Pedersen, Carsten Boe; O'Connor, Niall; Markey, Gerard; Moughty, Adrian; Lee, Christopher; O'Donohoe, Patrick; Sein Anand, Jacek; Puiguriguer, Jordi; ... (2017). Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicology letters, 277, pp. 84-91. Elsevier 10.1016/j.toxlet.2017.05.030
